Finance

Medicare Advantage insurtech company Clover Health and virtual care company Hims & Hers Health also reported earnings.

The Tennessee-based company has regained compliance with the bid price requirement to remain listed on the NASDAQ.

The company also seeks to sell its U.K. business to third parties, exit the U.S. market and continue trying to sell Meritage Medical Network.

The company reported second-quarter revenue of $18.5 million with a net loss of $28.7 million, alongside operating expenses totaling $42.2 million.

Informa Markets will manage the massive health technology conference, while HIMSS will continue overseeing content and programming.

Leaders from both organizations discuss the motivations behind and the goals of Informa Markets' deal to manage the HIMSS Global Health Conference and Exhibition.

The purchase comes on the heels of the surgical navigation platform's $82.5 million Series D raise in June.

Niall O'Connor, chief technology officer at Cohere Health, discusses how AI and machine learning can help streamline the prior authorization process by analyzing the totality of patient information and reducing denials by health plans.

The company will use the investment to fuel the expansion of Paradigm,its FDA-cleared, AI-enabled surgical navigation platform.

The company reported a 19% increase in revenue in the second quarter of this year compared to the prior year, driven by an 82% increase in B2B revenue.